Moreover, Shain et al. reported that NRAS and BRAF mutations may have a strict specificity regarding the type of nevi in which they occur, with BRAF V600E mutations being more frequent in benign lesions compared to NRAS mutations, which occur predominantly in intermediate precursor lesions, such as dysplastic nevi [75]. The gene discussed is BRAF; the disease is dysplastic nevus.